Theravance Biopharma Stock Forecast

Buy candidate since Jun 16, 2026 Loss -0.78%

The Theravance Biopharma stock price fell by -0.121% on the last day (Monday, 22nd Jun 2026) from $16.58 to $16.56. During the last trading day the stock fluctuated 3.09% from a day low at $16.41 to a day high of $16.92. The price has risen in 5 of the last 10 days and is up by 1.66% over the past 2 weeks. Volume has increased on the last day by 348 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $18.89 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.45% during the next 3 months and, with a 90% probability hold a price between $16.25 and $18.26 at the end of this 3-month period.

TBPH Signals & Forecast

The Theravance Biopharma stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $16.57. On a fall, the stock will find some support from the long-term average at approximately $16.45. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 6.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Theravance Biopharma stock

Theravance Biopharma finds support from accumulated volume at $16.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.507 between high and low, or 3.09%. For the last week the stock has had daily average volatility of 2.32%.

Our recommended stop-loss: $15.92 (-3.88%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (TBPH) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Theravance Biopharma to open at $16.63, and during the day (based on 14 day Average True Range), to move between $16.38 and $16.74, which gives a possible trading interval of +/-$0.357 (+/-2.18%) up or down from last closing price. If Theravance Biopharma takes out the full calculated possible swing range there will be an estimated 2.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.58 (0.12%) than the support at $16.37 (1.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Theravance Biopharma stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Theravance Biopharma stock to perform well in the short-term.

Current score: 3.349 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $16.63 ( 0.417%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk